Department of Medical Physics & Engineering, Osaka University Graduate School of Medicine, Suita, Japan.
Int J Radiat Oncol Biol Phys. 2010 Dec 1;78(5):1483-93. doi: 10.1016/j.ijrobp.2009.10.019. Epub 2010 Apr 6.
To evaluate the ongoing structure of radiation oncology in Japan in terms of equipment, personnel, patient load, and geographic distribution to identify and improve any deficiencies.
A questionnaire-based national structure survey was conducted from March to December 2008 by the Japanese Society of Therapeutic Radiology and Oncology (JASTRO). These data were analyzed in terms of the institutional stratification of the Patterns of Care Study.
The total numbers of new cancer patients and total cancer patients (new and repeat) treated with radiation in 2007 were estimated at 181,000 and 218,000, respectively. There were 807 linear accelerator, 15 telecobalt, 46 Gamma Knife, 45 (60)Co remote-controlled after-loading, and 123 (192)Ir remote-controlled after-loading systems in actual use. The linear accelerator systems used dual-energy function in 539 units (66.8%), three-dimensional conformal radiation therapy in 555 (68.8%), and intensity-modulated radiation therapy in 235 (29.1%). There were 477 JASTRO-certified radiation oncologists, 826.3 full-time equivalent (FTE) radiation oncologists, 68.4 FTE medical physicists, and 1,634 FTE radiation therapists. The number of interstitial radiotherapy (RT) administrations for prostate, stereotactic body radiotherapy, and intensity-modulated radiation therapy increased significantly. Patterns of Care Study stratification can clearly identify the maturity of structures based on their academic nature and caseload. Geographically, the more JASTRO-certified physicians there were in a given area, the more RT tended to be used for cancer patients.
The Japanese structure has clearly improved during the past 17 years in terms of equipment and its use, although a shortage of personnel and variations in maturity disclosed by Patterns of Care Study stratification were still problematic in 2007.
评估日本放射肿瘤学的现有结构,包括设备、人员、患者量和地理分布,以发现并改进不足之处。
2008 年 3 月至 12 月,日本治疗放射肿瘤学会(JASTRO)开展了一项基于问卷调查的全国范围结构调查。这些数据根据癌症治疗研究模式的机构分层进行了分析。
2007 年新癌症患者和接受放疗的总癌症患者(新发病例和复发病例)数量估计分别为 181000 和 218000。实际使用中的直线加速器有 807 台,远距离钴-60 治疗机 15 台,伽玛刀 46 台,后装遥控(60)钴 45 台和(192)铱 123 台。539 台直线加速器系统(66.8%)配备了双能功能,555 台(68.8%)配备了三维适形放疗,235 台(29.1%)配备了调强放疗。有 477 名 JASTRO 认证的放射肿瘤学家,826.3 名全职等效(FTE)放射肿瘤学家,68.4 名 FTE 医学物理学家和 1634 名 FTE 放射治疗师。前列腺间质内放疗(RT)、立体定向体部放疗和调强放疗的数量显著增加。癌症治疗研究模式的分层可以根据其学术性质和病例量清楚地识别结构的成熟度。从地域上看,某一地区 JASTRO 认证医生越多,接受 RT 治疗的癌症患者就越多。
尽管 2007 年人员短缺和癌症治疗研究模式分层显示的成熟度差异仍然存在问题,但与过去 17 年相比,日本的放射肿瘤学结构在设备及其使用方面有了明显改善。